FDA Approves Gene-Editing Treatment for Sickle Cell Disease garyglennell 3 years ago Click here for the report. Source: CBS News Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook NABJ & GBT to Host Sickle Cell Disease Barriers to CareDateMay 20, 2022In relation toWebinarsFDA Approves First New Alzheimer’s Drug in 20 YearsDateJune 7, 2021In relation toU.S. National NewsNAACP and Singleton Schreiber Partner to Pursue Justice for Sickle Cell Patients Harmed by Pfizer’s OxbrytaDateSeptember 2, 2025In relation toU.S. National News
